Devinez où était NicOx et avec qui les 15-16.9.09 ?

Support at Fever Pitch for Dynamic, Fresh Approach to Pharmaceutical Competitive Intelligence

PRNewswire/ -- It's a different era for pharmaceutical companies trying to remain on the forefront of an ever-changing industry while battling an uncertain economy. Now, more than ever, pharmaceutical competitive intelligence is the key to retaining market share and maintaining hard-earned industry relevancy. All decision makers need the powerful tools of pharmaceutical competitive intelligence.

The Pharma CI Conference & Exhibition is the industry's gold standard for senior level pharma, biotech, medical device, and diagnostics professionals who seek the latest in competitive intelligence/business intelligence. Last year's event sold out in record time! People packed rooms beyond capacity! And 2009 is on track for another banner year. Anticipation is growing for the 2009 Pharma CI Conference on September 15-16th; it's hands-down the premier event for networking with the industry's luminaries, and gaining insight from cutting edge speakers who are ahead of the curve.

The Pharma CI Conference delivers a fresh approach to addressing complex issues. There are 40+ different sessions planned to customize participation. Some of the topics include the following:

The Biopharmaceutical Industry Can Adapt To Change For A Brighter Future
Customized Healthcare in a Comparative Effectiveness World
Developing a Counter-Intelligence System
Follow-on Biologics: Political Landscape and Key Provisions
Managed Markets, Formularies & You: The Use of Competitive Intelligence to Understand the Most Influential Growth Sales and Marketing Category
Future and Competitor Proofing Your Strategy
Leveraging CI to Optimize Late Lifecycle Strategic Planning
And many more...
The expert speaking faculty consists of 60+ senior level executives from these world-class companies: APP Pharmaceuticals, ArthroCare, Astellas, Baxter Corporation, Bayer Healthcare, Biovail, Boehringer Ingelheim, Boston Scientific, Bristol-Myers Squibb, Depuy Spine (J&J), DSM Pharmaceuticals, Dyax Corporation, Eisai, Ethicon, a Johnson& Johnson Company, Exelixis, Gen-Probe, Genentech, General Electric, Genzyme, GlaxoSmithKline, Lifescan, Medtronic, Merck, Millennium Pharmaceuticals, Nicox, Novartis, Pfizer, Roche Diagnostics, Sanofi-Aventis, Smith & Nephew, Thermo Fisher Scientific, Vertex, and Wyeth.

A preliminary listing of sponsors/exhibitors include the following companies: Best Practices, BioMedTracker, Bioxcel, Deallus, Digimind, Dolcera, Dunn Group, Fletcher/CSI, Fuld & Company, Indegene, InfoNgen, I.S.I.S., Inc., Lifescience Dynamics, MedPredict, PharmaForce, Pharmavoxx, and Sedulo Group.

The Pharma CI Conference & Exhibition will be held September 15-16, 2009 at the Sheraton Parsippany Hotel, New Jersey. For more information, or to register, go to www.Pharmaciconference.com. You can also call 212.228.7974 or email info@pharmaciconference.com.

SOURCE The Pharma CI Conference & Exhibition

http://www.ct-partnerships.com/page.cfm?pageID=1455

Partnerships

in Clinical Trials 2009

4-5 November, World Trade Centre, Rotterdam, The Netherlands


THE FUTURE OF
SUCCESSFUL
PARTNERING IN SMALL
PHARMA/BIOTECH
Chair: Alan J Wood, PhD, Senior Director,
R&D Operations, NicOx S.A.

Alors ça mange à la même cantine..?

et qu'est-ce qui se raconte..?

se compose de 60 cadres supérieurs de
ces entreprises de classe mondiale:
APP Pharmaceuticals,
ArthroCare,

Astellas,
Baxter Corporation,
Bayer Healthcare,
Biovail,
Boehringer
Ingelheim,
Boston Scientific,
Bristol-Myers Squibb,
DePuy Spine (J
& J),
DSM Pharmaceuticals,
Dyax Corporation,
Eisai,
Ethicon,

Johnson & Johnson Company,
Exelixis,
Gen-Probe,
Genentech,
General
Electric,
Genzyme,
GlaxoSmithKline,
Lifescan,
Medtronic,
Merck,

Millennium Pharmaceuticals,
NicOx,
Novartis,
Pfizer,
Roche Diagnostics,

Sanofi - Aventis,
Smith & Nephew,
Thermo Fisher Scientific,
Vertex,
et
Wyeth.

on le retrouve aussi en decembre

http://www.iir-events.com/IIR-conf/LifeSciences/EventPages.aspx?EventID=2453&SerialNo=1


16:30
Panel discussion: Milestone driven payments versus running costs –
establishing a robust payment schedule once an overall budget is agreed
upon

• What type of payment structures do CROs and sponsors prefer and how do they differ?

• What are the best ways of costing services? Examining of the various pricing models and use of bid-grids

• Costing of full service package vs. using specialised CROs for each task

• How to strike a fair balance between sponsor and provider regarding payment structures



Alan J Wood, Senior Director, R&D Operations, NicOx S.A.



Richard Barrett, Contract & Outsourcing Services Ltd



Graham P Belgrave, Pharmaceutical Outsourcing Consultant


----------------------------------------------------------------


09:00 Opening remarks from the Chair



Alan J Wood, Senior Director, R&D Operations, NicOx S.A.




Building
and planning a successful, cost-effective budget plan for your clinical
trial programme: What is fair market, realistic and actually possible?